PharmaVOICE Blog Post

The State of Real World Evidence (RWE) – Infographic

Posted By: Dan Limbach
March 9, 2020

From R&D, to pre-launch and launch phases, to post-market surveillance and commercial performance –

Real-World Evidence (RWE) has shown immense value for companies that have invested the resources to track, measure, and apply it meaningfully.

This infographic breaks down the state of RWE in biopharma by growth trends, internal knowledge and expertise within biopharma companies, top challenges leveraging RWE, its use across R&D and regulatory, and its uses in commercial phases.

Sneak Peek: Access to quality data is the #1 challenge, according to the research.

See the full infographic:

About the Blog Poster: Dan Limbach

Post a Comment

You must be logged in to post a Comment.